Molecular glues Market Revenue to Attain USD 11.59 Bn by 2035

Published: 01 Apr 2026

Author: Precedence Research

Share:

Molecular glues Market Revenue and Trends 2026 to 2035

The global molecular glues market revenue surpassed USD 2.65 billion in 2025 and is predicted to attain around USD 11.59 billion by 2035, growing at a CAGR of 15.90%. This market is experiencing unprecedented growth, driven by the rising adoption of Targeted Protein Degradation (TPD) and rapid advancements in AI-driven drug discovery.

What are the Major Factors Contributing to the Growth of the Molecular Glues Market?

The rising global incidence of cancer, neurodegenerative diseases, infectious diseases, and autoimmune disorders is the major factor contributing to the overall growth of the market. Molecular glues are a groundbreaking class of small molecules that are gaining immense popularity in the field of drug discovery. These compounds provide a novel approach for modulating protein function. Molecular glues offer several advantages over traditional drug delivery methods, which can be specifically engineered to target specific cells or tissues, enhancing treatment efficacy.

The significant rise in R&D investment and strategic collaborations between major pharmaceutical companies and biotech startups is significantly accelerating the pipeline. The market’s growth is also primarily supported by the rising shift from serendipitous discovery to high-throughput screening and AI-driven ligand design that allows for faster identification of novel binders.

Segment Insights

• By type, the monovalent molecular glues segment held the largest market share of 62.0% in 2025 due to their superior drug-like properties, reduced manufacturing complexity, and ability to target previously "undruggable" proteins. Their small size allows for oral administration, which is highly preferred over parenteral administration.
• By application, the oncology segment accounted for the largest market share of 78% in 2025, owing to the increasing need to target "undruggable" cancer-driving proteins, superior oral bioavailability, and proven high clinical success in hematological malignancies. The rise in approval from the FDA to use IMiDs for multiple myeloma and myelodysplastic syndromes has established molecular glues as a high-revenue therapeutic class.
• By technology/process, the phenotypic screening segment registered its dominance by holding the largest market share in 2025. Phenotypic screening enables researchers to observe the effects of compounds on living cells. Molecular glue degraders (MGDs) often operate through complex and unpredictable mechanisms that often become difficult to anticipate using rational design.
• By end user, the pharmaceutical & biotechnology companies segment held a major revenue share in the market in 2025, owing to their significant R&D investment capabilities, strategic collaborations, and the enhanced ability to leverage established small-molecule drug development infrastructure.

Regional Insights

North America dominated the global molecular glues market by holding the highest market share of 42.0% in 2025. The robust presence of specialized biotechnology firms and well-established research institutions drives rapid innovation and enables the discovery of new molecular glues for "undruggable" proteins. The region's dominance is characterized by the advanced healthcare infrastructure, high concentration of pharmaceutical & biotech companies, increasing elderly population, increasing prevalence of chronic diseases, supportive regulatory environment, and significant investment in targeted protein degradation (TPD). Beyond oncology, several pharmaceutical companies are increasingly focusing on expanding molecular glue applications into autoimmune diseases and neurological disorders.

On the other hand, Asia Pacific is a rapidly growing region in the market. This is because of the rising investments in next-generation therapeutics, with countries such as China, India, South Korea, and Japan at the forefront of developing innovative molecular glues. The region's fastest growth is attributed to the robust biotech ecosystem, rising focus on innovative drug development, rise in R&D investment, strong government support, and rapid technological innovation. Additionally, the increasing incidences of cancer and other complex diseases in the region have significantly increased the demand for novel therapeutics, which further encourages investments in advanced molecular glue degradation agents, driving the expansion of the market in the region during the forecast period.

Molecular glues Market Coverage

Recent Developments

• In July 2025, PhoreMost released new data validating its GlueSEEKER platform, a high-throughput technology designed to accelerate the discovery of molecular glue drugs. This study outlines a systematic approach for engineering effector proteins, such as E3 ligases, to induce targeted protein degradation. GlueSEEKER combines high-throughput biological data with computational drug discovery tools, offering comprehensive blueprints for the development of small molecules. (Source: https://pharmatimes.com)

Get this report to explore global market size, share, CAGR, and trends, featuring detailed segmental analysis and an insightful competitive landscape overview @ https://www.precedenceresearch.com/sample/8260

You can place an order or ask any questions, please feel free to contact us at sales@precedenceresearch.com |+1 804 441 9344